日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity

发现 AMG 133,一种葡萄糖依赖性胰岛素促泌多肽受体拮抗剂和胰高血糖素样肽-1受体激动剂抗体-药物偶联物,用于治疗肥胖症

Wu, Bin; Falsey, James R; Netirojjanakul, Chawita; Herberich, Brad; Holder, Jerry Ryan; Sham, Kelvin; Aral, Jennifer; Forsythe, Neil; Walker, Kenneth W; Lu, Shu-Chen; Hager, Todd; Stanislaus, Shanaka; Komorowski, Renee; Atangan, Larissa; Achmatowicz, Michal; Romanini, Dante; Weeraratne, Dohan; Miranda, Les P; Véniant, Murielle M; Cheng, Yuan

Development of cytokinin activity by rearrangement of 1-substituted adenines to 6-substituted aminopurines: inactivation by N6, 1-cyclization

细胞分裂素活性的产生是通过1-取代腺嘌呤重排为6-取代氨基嘌呤实现的:N6,1-环化可使其失活

Leonard, N J; Achmatowicz, S; Loeppky, R N; Carraway, K L; Grimm, W A; Szweykowska, A; Hamzi, Q H; Skoog, F